{
  "quizTitle": "Immunology Quiz Q171-200",
  "questions": [
    {
      "id": 171,
      "question": "Which of the following is an example of passive immunotherapy?",
      "options": [
        "CAR-T cell therapy",
        "HPV vaccine",
        "Rituximab (monoclonal antibody)",
        "Immune checkpoint inhibitors",
        "Cancer vaccines"
      ],
      "answer": "Rituximab (monoclonal antibody)",
      "key": "Passive Immunotherapy Example"
    },
    {
      "id": 172,
      "question": "What is a common use of active immunotherapy in cancer treatment?",
      "options": [
        "To directly kill cancer cells using monoclonal antibodies",
        "To stimulate the immune system to recognize and attack cancer cells",
        "To provide immediate immune support in cancer patients",
        "To supply antibodies directly to the bloodstream",
        "To neutralize toxins produced by cancer cells"
      ],
      "answer": "To stimulate the immune system to recognize and attack cancer cells",
      "key": "Active Immunotherapy for Cancer"
    },
    {
      "id": 173,
      "question": "Which of the following is a limitation of passive immunotherapy?",
      "options": [
        "It provides long-term immunity",
        "It requires the patient’s immune system to be activated",
        "It can cause allergic reactions or immune responses against the antibodies",
        "It stimulates the production of immune cells",
        "It works best in patients with strong immune systems"
      ],
      "answer": "It can cause allergic reactions or immune responses against the antibodies",
      "key": "Passive Immunotherapy Limitation"
    },
    {
      "id": 174,
      "question": "Which of the following is NOT a characteristic of active immunotherapy?",
      "options": [
        "Long-lasting immune responses",
        "Stimulation of the body’s immune system",
        "Immediate immune protection",
        "Creation of immune memory",
        "Used in cancer and infectious disease treatments"
      ],
      "answer": "Immediate immune protection",
      "key": "Not a Characteristic of Active Immunotherapy"
    },
    {
      "id": 175,
      "question": "Which of the following types of therapy is based on providing temporary immunity by administering antibodies from another source?",
      "options": [
        "Vaccination",
        "Passive immunotherapy",
        "Active immunotherapy",
        "Chemotherapy",
        "Immunosuppression therapy"
      ],
      "answer": "Passive immunotherapy",
      "key": "Temporary Immunity via Antibodies"
    },
    {
      "id": 176,
      "question": "What is the primary goal of immunosuppression therapy?",
      "options": [
        "To boost the immune system",
        "To prevent rejection of transplanted organs",
        "To stimulate an allergic reaction",
        "To create immune memory",
        "To fight bacterial infections"
      ],
      "answer": "To prevent rejection of transplanted organs",
      "key": "Immunosuppression Therapy Goal"
    },
    {
      "id": 177,
      "question": "Which of the following is an immunosuppressive drug?",
      "options": [
        "Penicillin",
        "Cyclosporine",
        "Insulin",
        "Aspirin",
        "Epinephrine"
      ],
      "answer": "Cyclosporine",
      "key": "Immunosuppressive Drug Example"
    },
    {
      "id": 178,
      "question": "Why are immunosuppressive drugs necessary for organ transplantation?",
      "options": [
        "To prevent viral infections",
        "To increase blood flow to the new organ",
        "To prevent the recipient's immune system from attacking the new organ",
        "To promote tissue growth",
        "To reduce inflammation"
      ],
      "answer": "To prevent the recipient's immune system from attacking the new organ",
      "key": "Immunosuppression in Organ Transplantation"
    },
    {
      "id": 179,
      "question": "What is the primary mechanism of action of corticosteroids as immunosuppressants?",
      "options": [
        "Blocking T cell activation",
        "Inhibiting B cell proliferation",
        "Inducing apoptosis in immune cells",
        "Blocking the production of inflammatory cytokines",
        "Stimulating antibody production"
      ],
      "answer": "Blocking the production of inflammatory cytokines",
      "key": "Corticosteroid Mechanism"
    },
    {
      "id": 180,
      "question": "Which of the following is a common side effect of long-term immunosuppressant use?",
      "options": [
        "Increased risk of infection",
        "Heightened immune response",
        "Decreased risk of cancer",
        "Rapid wound healing",
        "Lower blood pressure"
      ],
      "answer": "Increased risk of infection",
      "key": "Immunosuppressant Side Effect"
    },
    {
      "id": 181,
      "question": "What type of therapy is used to treat autoimmune diseases by suppressing the overactive immune system?",
      "options": [
        "Active immunotherapy",
        "Passive immunotherapy",
        "Immunosuppression therapy",
        "Vaccination",
        "Gene therapy"
      ],
      "answer": "Immunosuppression therapy",
      "key": "Therapy for Autoimmune Diseases"
    },
    {
      "id": 182,
      "question": "What is the function of immune checkpoint inhibitors?",
      "options": [
        "To suppress the immune system",
        "To block T-cell activity",
        "To release the 'brakes' on the immune system to allow it to attack cancer cells",
        "To directly kill cancer cells",
        "To replace damaged immune cells"
      ],
      "answer": "To release the 'brakes' on the immune system to allow it to attack cancer cells",
      "key": "Immune Checkpoint Inhibitor Function"
    },
    {
      "id": 183,
      "question": "Which type of vaccine uses weakened or attenuated pathogens to trigger an immune response?",
      "options": [
        "Killed/inactivated vaccine",
        "Subunit vaccine",
        "Live-attenuated vaccine",
        "Toxoid vaccine",
        "mRNA vaccine"
      ],
      "answer": "Live-attenuated vaccine",
      "key": "Vaccine Type: Weakened Pathogens"
    },
    {
      "id": 184,
      "question": "Which type of vaccine uses a piece of genetic material (like mRNA or DNA) to teach the body how to make a protein that triggers an immune response?",
      "options": [
        "Toxoid vaccine",
        "Live-attenuated vaccine",
        "mRNA/DNA vaccine",
        "Conjugate vaccine",
        "Whole-cell vaccine"
      ],
      "answer": "mRNA/DNA vaccine",
      "key": "Vaccine Type: Genetic Material"
    },
    {
      "id": 185,
      "question": "Which of the following is a key component of a subunit vaccine?",
      "options": [
        "The whole, live pathogen",
        "The whole, killed pathogen",
        "A piece of the pathogen, like a protein",
        "A weakened toxin",
        "Genetic material"
      ],
      "answer": "A piece of the pathogen, like a protein",
      "key": "Subunit Vaccine Component"
    },
    {
      "id": 186,
      "question": "How do vaccines provide long-term immunity?",
      "options": [
        "By directly neutralizing pathogens",
        "By suppressing the immune system",
        "By producing memory cells that can recognize the pathogen in the future",
        "By providing a constant supply of antibodies",
        "By inhibiting viral replication"
      ],
      "answer": "By producing memory cells that can recognize the pathogen in the future",
      "key": "Vaccine Mechanism for Long-term Immunity"
    },
    {
      "id": 187,
      "question": "What is herd immunity?",
      "options": [
        "Immunity that develops after a person has had an infection",
        "Immunity provided by a vaccine",
        "Protection from a disease that occurs when a large percentage of a population is immune",
        "Immunity transferred from mother to child",
        "Immunity against all types of pathogens"
      ],
      "answer": "Protection from a disease that occurs when a large percentage of a population is immune",
      "key": "Herd Immunity Definition"
    },
    {
      "id": 188,
      "question": "Which of the following is an example of an inactivated vaccine?",
      "options": [
        "Measles, Mumps, Rubella (MMR)",
        "Polio (Salk vaccine)",
        "Varicella (chickenpox)",
        "Tetanus toxoid",
        "Smallpox vaccine"
      ],
      "answer": "Polio (Salk vaccine)",
      "key": "Inactivated Vaccine Example"
    },
    {
      "id": 189,
      "question": "What is the function of an adjuvant in a vaccine?",
      "options": [
        "To kill the pathogen",
        "To prevent allergic reactions",
        "To enhance the immune response to the antigen",
        "To make the vaccine last longer",
        "To reduce pain at the injection site"
      ],
      "answer": "To enhance the immune response to the antigen",
      "key": "Adjuvant Function"
    },
    {
      "id": 190,
      "question": "Which of the following is a limitation of live-attenuated vaccines?",
      "options": [
        "They are expensive to produce",
        "They do not provide long-term immunity",
        "They can sometimes revert to a virulent form",
        "They are not effective for most diseases",
        "They require multiple doses"
      ],
      "answer": "They can sometimes revert to a virulent form",
      "key": "Live-Attenuated Vaccine Limitation"
    },
    {
      "id": 191,
      "question": "What is the primary function of a toxoid vaccine?",
      "options": [
        "To induce an immune response against a viral protein",
        "To stimulate an immune response against a bacterial toxin",
        "To kill bacteria directly",
        "To prevent a virus from replicating",
        "To suppress the immune system"
      ],
      "answer": "To stimulate an immune response against a bacterial toxin",
      "key": "Toxoid Vaccine Function"
    },
    {
      "id": 192,
      "question": "Which type of vaccine is most suitable for immunocompromised individuals?",
      "options": [
        "Live-attenuated vaccines",
        "Inactivated or subunit vaccines",
        "Toxoid vaccines",
        "mRNA vaccines",
        "DNA vaccines"
      ],
      "answer": "Inactivated or subunit vaccines",
      "key": "Vaccine for Immunocompromised"
    },
    {
      "id": 193,
      "question": "What is a major advantage of mRNA vaccines?",
      "options": [
        "They are easy to store and transport",
        "They can be produced quickly and in large quantities",
        "They use a weakened virus",
        "They are effective against all types of diseases",
        "They do not require a cold chain"
      ],
      "answer": "They can be produced quickly and in large quantities",
      "key": "mRNA Vaccine Advantage"
    },
    {
      "id": 194,
      "question": "Which of the following is an example of a toxoid vaccine?",
      "options": [
        "Polio (Salk)",
        "Measles",
        "Tetanus",
        "Hepatitis B",
        "Influenza"
      ],
      "answer": "Tetanus",
      "key": "Toxoid Vaccine Example"
    },
    {
      "id": 195,
      "question": "How does a conjugate vaccine work?",
      "options": [
        "It uses a live, weakened pathogen",
        "It attaches a weak antigen to a strong protein carrier to improve the immune response",
        "It uses a whole, killed pathogen",
        "It uses mRNA to produce a protein antigen",
        "It uses a bacterial toxin"
      ],
      "answer": "It attaches a weak antigen to a strong protein carrier to improve the immune response",
      "key": "Conjugate Vaccine Mechanism"
    },
    {
      "id": 196,
      "question": "What is the primary goal of cancer vaccines?",
      "options": [
        "To provide immediate protection against cancer cells",
        "To stimulate the immune system to recognize and attack cancer cells",
        "To replace chemotherapy as a treatment",
        "To prevent all types of cancer",
        "To suppress the immune system to prevent cancer growth"
      ],
      "answer": "To stimulate the immune system to recognize and attack cancer cells",
      "key": "Cancer Vaccine Goal"
    },
    {
      "id": 197,
      "question": "What is the main challenge in developing cancer vaccines?",
      "options": [
        "The immune system is not able to recognize cancer cells as foreign",
        "Cancer cells are all identical",
        "It is too expensive to produce them",
        "They are not effective against any type of cancer",
        "Cancer vaccines do not induce a memory response"
      ],
      "answer": "The immune system is not able to recognize cancer cells as foreign",
      "key": "Cancer Vaccine Challenge"
    },
    {
      "id": 198,
      "question": "Which of the following is NOT an advantage of subunit vaccines?",
      "options": [
        "They are safe for immunocompromised individuals",
        "They cannot cause the disease",
        "They are easy to produce",
        "They can cause strong, long-lasting immunity",
        "They contain only a few antigens"
      ],
      "answer": "They can cause strong, long-lasting immunity",
      "key": "Not an Advantage of Subunit Vaccines"
    },
    {
      "id": 199,
      "question": "What is the purpose of therapeutic cancer vaccines?",
      "options": [
        "To prevent cancer in healthy individuals",
        "To treat existing cancer by stimulating an anti-tumor immune response",
        "To provide passive immunity against cancer",
        "To prevent the spread of cancer to other parts of the body",
        "To directly kill cancer cells"
      ],
      "answer": "To treat existing cancer by stimulating an anti-tumor immune response",
      "key": "Therapeutic Cancer Vaccine Purpose"
    },
    {
      "id": 200,
      "question": "Which of the following is an example of an mRNA vaccine?",
      "options": [
        "Polio vaccine",
        "Tetanus vaccine",
        "Hepatitis B vaccine",
        "Pfizer-BioNTech COVID-19 vaccine",
        "MMR vaccine"
      ],
      "answer": "Pfizer-BioNTech COVID-19 vaccine",
      "key": "mRNA Vaccine Example"
    }
  ]
}